PubMed:32979436
Annnotations
LitCovid_Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 863-870 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T2 | 863-870 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
T3 | 1007-1014 | https://glytoucan.org/Structures/Glycans/G00021MO | denotes | heparin |
T4 | 1007-1014 | https://glytoucan.org/Structures/Glycans/G54161DR | denotes | heparin |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 76-89 | Body_part | denotes | glycoproteins | http://purl.org/sig/ont/fma/fma62925 |
T2 | 184-197 | Body_part | denotes | glycoproteins | http://purl.org/sig/ont/fma/fma62925 |
T3 | 329-341 | Body_part | denotes | cell surface | http://purl.org/sig/ont/fma/fma67653 |
T4 | 329-333 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T5 | 342-357 | Body_part | denotes | heparan sulfate | http://purl.org/sig/ont/fma/fma63023 |
T6 | 359-361 | Body_part | denotes | HS | http://purl.org/sig/ont/fma/fma63023 |
T7 | 427-431 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
T8 | 473-488 | Body_part | denotes | polysaccharides | http://purl.org/sig/ont/fma/fma82746 |
T9 | 607-622 | Body_part | denotes | polysaccharides | http://purl.org/sig/ont/fma/fma82746 |
T10 | 624-640 | Body_part | denotes | oligosaccharides | http://purl.org/sig/ont/fma/fma82742 |
T11 | 863-870 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
T12 | 1007-1014 | Body_part | denotes | heparin | http://purl.org/sig/ont/fma/fma82839 |
T13 | 1128-1136 | Body_part | denotes | backbone | http://purl.org/sig/ont/fma/fma13478 |
T14 | 1302-1310 | Body_part | denotes | backbone | http://purl.org/sig/ont/fma/fma13478 |
T15 | 1510-1525 | Body_part | denotes | polysaccharides | http://purl.org/sig/ont/fma/fma82746 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 59-67 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T2 | 167-175 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T3 | 314-322 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T4 | 392-400 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T5 | 677-685 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T6 | 843-851 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T7 | 934-942 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T8 | 1471-1479 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T9 | 1582-1590 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 14-22 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T2 | 209-214 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
T3 | 329-333 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T4 | 427-431 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
T5 | 461-462 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T6 | 557-565 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T7 | 1032-1034 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 27 |
T8 | 1126-1127 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T9 | 1182-1184 | http://purl.obolibrary.org/obo/CLO_0037284 | denotes | C4 |
T10 | 1189-1191 | http://purl.obolibrary.org/obo/CLO_0002105 | denotes | C2 |
T11 | 1189-1191 | http://purl.obolibrary.org/obo/CLO_0051742 | denotes | C2 |
T12 | 1192-1194 | http://purl.obolibrary.org/obo/CLO_0037284 | denotes | C4 |
T13 | 1241-1243 | http://purl.obolibrary.org/obo/CLO_0037284 | denotes | C4 |
T14 | 1300-1301 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 76-89 | Chemical | denotes | glycoproteins | http://purl.obolibrary.org/obo/CHEBI_17089 |
T2 | 184-197 | Chemical | denotes | glycoproteins | http://purl.obolibrary.org/obo/CHEBI_17089 |
T3 | 215-226 | Chemical | denotes | angiotensin | http://purl.obolibrary.org/obo/CHEBI_48433 |
T4 | 342-357 | Chemical | denotes | heparan sulfate | http://purl.obolibrary.org/obo/CHEBI_28815 |
T5 | 342-349 | Chemical | denotes | heparan | http://purl.obolibrary.org/obo/CHEBI_24500 |
T6 | 350-357 | Chemical | denotes | sulfate | http://purl.obolibrary.org/obo/CHEBI_16189 |
T7 | 359-361 | Chemical | denotes | HS | http://purl.obolibrary.org/obo/CHEBI_74056|http://purl.obolibrary.org/obo/CHEBI_28815 |
T9 | 473-488 | Chemical | denotes | polysaccharides | http://purl.obolibrary.org/obo/CHEBI_18154 |
T10 | 607-622 | Chemical | denotes | polysaccharides | http://purl.obolibrary.org/obo/CHEBI_18154 |
T11 | 624-640 | Chemical | denotes | oligosaccharides | http://purl.obolibrary.org/obo/CHEBI_50699 |
T12 | 762-765 | Chemical | denotes | D-S | http://purl.obolibrary.org/obo/CHEBI_73454 |
T13 | 863-870 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
T14 | 982-985 | Chemical | denotes | D-S | http://purl.obolibrary.org/obo/CHEBI_73454 |
T15 | 1007-1014 | Chemical | denotes | heparin | http://purl.obolibrary.org/obo/CHEBI_28304 |
T16 | 1106-1109 | Chemical | denotes | D-S | http://purl.obolibrary.org/obo/CHEBI_73454 |
T17 | 1189-1191 | Chemical | denotes | C2 | http://purl.obolibrary.org/obo/CHEBI_30083 |
T18 | 1510-1525 | Chemical | denotes | polysaccharides | http://purl.obolibrary.org/obo/CHEBI_18154 |
LitCovid-PD-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
---|---|---|---|---|---|
T1 | 342-357 | GlycoEpitope | denotes | heparan sulfate | http://www.glycoepitope.jp/epitopes/EP0086 |
T2 | 359-361 | GlycoEpitope | denotes | HS | http://www.glycoepitope.jp/epitopes/EP0086 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
4 | 59-69 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
5 | 95-110 | Chemical | denotes | glucuronomannan | MESH:C578162 |
6 | 124-136 | Chemical | denotes | galactofucan | |
7 | 142-161 | Species | denotes | Saccharina japonica | Tax:88149 |
39 | 167-177 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
40 | 209-214 | Species | denotes | human | Tax:9606 |
41 | 215-246 | Gene | denotes | angiotensin converting enzyme 2 | Gene:59272 |
42 | 248-252 | Gene | denotes | ACE2 | Gene:59272 |
43 | 314-322 | Disease | denotes | COVID-19 | MESH:C000657245 |
44 | 342-357 | Chemical | denotes | heparan sulfate | MESH:D006497 |
45 | 359-361 | Chemical | denotes | HS | MESH:D006497 |
46 | 392-402 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
47 | 473-488 | Chemical | denotes | polysaccharides | MESH:D011134 |
48 | 494-513 | Species | denotes | Saccharina japonica | Tax:88149 |
49 | 607-622 | Chemical | denotes | polysaccharides | MESH:D011134 |
50 | 624-640 | Chemical | denotes | oligosaccharides | MESH:D009844 |
51 | 677-687 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
52 | 698-702 | Gene | denotes | ACE2 | Gene:59272 |
53 | 745-757 | Chemical | denotes | galactofucan | |
54 | 773-788 | Chemical | denotes | glucuronomannan | MESH:C578162 |
55 | 843-853 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
56 | 863-870 | Chemical | denotes | heparin | MESH:D006493 |
57 | 934-944 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
58 | 954-958 | Gene | denotes | ACE2 | Gene:59272 |
59 | 1007-1014 | Chemical | denotes | heparin | MESH:D006493 |
60 | 1152-1160 | Chemical | denotes | α-L-Fucp | |
61 | 1211-1219 | Chemical | denotes | α-L-Fucp | |
62 | 1293-1295 | Chemical | denotes | Gn | MESH:C578162 |
63 | 1326-1347 | Chemical | denotes | 1, 4-linked β-D-GlcAp | |
64 | 1373-1381 | Chemical | denotes | α-D-Manp | |
65 | 1405-1417 | Chemical | denotes | galactofucan | |
66 | 1422-1437 | Chemical | denotes | glucuronomannan | MESH:C578162 |
67 | 1471-1481 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
68 | 1510-1525 | Chemical | denotes | polysaccharides | MESH:D011134 |
69 | 1582-1592 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-162 | Sentence | denotes | The structure-activity relationship of the interactions of SARS-CoV-2 spike glycoproteins with glucuronomannan and sulfated galactofucan from Saccharina japonica. |
T2 | 163-323 | Sentence | denotes | The SARS-CoV-2 spike glycoproteins (SGPs) and human angiotensin converting enzyme 2 (ACE2) are the two key targets for the prevention and treatment of COVID-19. |
T3 | 324-438 | Sentence | denotes | Host cell surface heparan sulfate (HS) is believed to interact with SARS-CoV-2 SGPs to facilitate host cell entry. |
T4 | 439-735 | Sentence | denotes | In the current study, a series of polysaccharides from Saccharina japonica were prepared to investigate the structure-activity relationship on the binding abilities of polysaccharides (oligosaccharides) to pseudotype particles, including SARS-CoV-2 SGPs, and ACE2 using surface plasmon resonance. |
T5 | 736-959 | Sentence | denotes | Sulfated galactofucan (SJ-D-S-H) and glucuronomannan (Gn) displayed strongly inhibited interaction between SARS-CoV-2 SGPs and heparin while showing negligible inhibition of the interaction between SARS-CoV-2 SGPs and ACE2. |
T6 | 960-1060 | Sentence | denotes | The IC50 values of SJ-D-S-H and Gn in blocking heparin SGP binding were 27 and 231 nM, respectively. |
T7 | 1061-1391 | Sentence | denotes | NMR analysis showed that the structure of SJ-D-S-H featured with a backbone of 1, 3-linked α-L-Fucp residues sulfated at C4 and C2/C4 and 1, 3-linked α-L-Fucp residues sulfated at C4 and branched with 1, 6-linked β-D-galacto-biose; Gn had a backbone of alternating 1, 4-linked β-D-GlcAp residues and 1, 2-linked α-D-Manp residues. |
T8 | 1392-1593 | Sentence | denotes | The sulfated galactofucan and glucuronomannan showed strong binding ability to SARS-CoV-2 SGPs, suggesting that these polysaccharides might be good candidates for preventing and/or treating SARS-CoV-2. |